30-Mar-2026 9:33 PM CST - Yahoo Finance Boston Scientific (BSX) Stock Trades Down, Here Is Why Shares of medical device company Boston Scientific (NYSE:BSX) fell 9.4% in the afternoon session after Raymond James downgraded the stock to Outperform from Strong Buy, citing worries about the company's growth prospects.
18-Mar-2026 9:07 AM CST - Yahoo Finance Sacral neuromodulation: broadening Boston Scientific's European urology portfolio Boston Scientific is taking clear steps to advance its European, Middle East and Africa (EMEA) region market position in the urology space. The company drew significant attention at the J.P. Morgan Healthcare conference in January 2026 for its acquisition of urinary incontinence specialist Valencia Technologies.
16-Mar-2026 6:53 AM CST - Yahoo Finance Boston Scientific Lawsuits Put Electrophysiology Outlook And Valuation In Focus Multiple securities class action lawsuits have been filed against Boston Scientific (NYSE:BSX) over disclosures about its U.S. Electrophysiology segment. Plaintiffs allege the company misled investors about growth prospects and competitive threats in this business line.
7-Mar-2026 11:52 PM CST - Yahoo Finance Boston Scientific Recall And Lawsuits Test Earnings Power And Capital Plans Boston Scientific (NYSE:BSX) is facing multiple new securities class action lawsuits tied to disappointing earnings, lowered sales guidance, and a Class I recall of its AXIOS Stent and Delivery Systems.
Latest BSX Trades by Congress Members
10-FEB-2026 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.
30-Mar-2026 9:33 PM CST - Yahoo Finance Boston Scientific (BSX) Stock Trades Down, Here Is Why Shares of medical device company Boston Scientific (NYSE:BSX) fell 9.4% in the afternoon session after Raymond James downgraded the stock to Outperform from Strong Buy, citing worries about the company's growth prospects.
18-Mar-2026 9:07 AM CST - Yahoo Finance Sacral neuromodulation: broadening Boston Scientific's European urology portfolio Boston Scientific is taking clear steps to advance its European, Middle East and Africa (EMEA) region market position in the urology space. The company drew significant attention at the J.P. Morgan Healthcare conference in January 2026 for its acquisition of urinary incontinence specialist Valencia Technologies.
16-Mar-2026 6:53 AM CST - Yahoo Finance Boston Scientific Lawsuits Put Electrophysiology Outlook And Valuation In Focus Multiple securities class action lawsuits have been filed against Boston Scientific (NYSE:BSX) over disclosures about its U.S. Electrophysiology segment. Plaintiffs allege the company misled investors about growth prospects and competitive threats in this business line.
7-Mar-2026 11:52 PM CST - Yahoo Finance Boston Scientific Recall And Lawsuits Test Earnings Power And Capital Plans Boston Scientific (NYSE:BSX) is facing multiple new securities class action lawsuits tied to disappointing earnings, lowered sales guidance, and a Class I recall of its AXIOS Stent and Delivery Systems.
